DLO6002
DLO6002 Uses, Dosage, Side Effects, Food Interaction and all others data.
DLO6002 is developed by Summit Corporation and is in phase I of clinical trials for the treatment of Parkinson's disease.
Trade Name | DLO6002 |
Generic | DLO6002 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in parkinson's disease.
Innovators Monograph
You find simplified version here DLO6002